Expression profiling of DNA methylation-mediated epigenetic gene-silencing factors in breast cancer

Clinical Epigenetics

Volumn 6, Issue 1, 2014, Pages

  Kar, Swayamsiddha ^a   Sengupta, Dipta ^a   Deb, Moonmoon ^a   Shilpi, Arunima ^a   Parbin, Sabnam ^a   Rath, Sandip Kumar ^a   Pradhan, Nibedita ^a   Rakshit, Madhumita ^a   Patra, Samir Kumar ^a  

^a NATIONAL INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Cancer; DNA methylation; DNA methyltransferases; Epigenetics; Gene silencing; Methyl CpG binding domain proteins

Indexed keywords

DECITABINE; DNA; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; MESSENGER RNA; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 1; METHYL CPG BINDING PROTEIN 2; METHYL CPG BINDING PROTEIN 3; METHYL CPG BINDING PROTEIN 4; S ADENOSYLMETHIONINE; SULFORAPHANE; TRICHOSTATIN A; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER STAGING; CELL VIABILITY; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FLUORESCENCE ACTIVATED CELL SORTING; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION PROFILING; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MCF 7 CELL LINE; MDA MB 231 CELL LINE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SPECIFICITY;

EID: 84954415497     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/1868-7083-6-20     Document Type: Article

References (43)

1. Jaenisch R, Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003, 33: 245-254.
2. Klose RJ, Bird AP: Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006, 31: 89-97.
3. Patra SK, Deb M, Patra A: Molecular marks for epigenetic identification of developmental and cancer stem cells. Clin Epigenet 2011, 2: 27-53.
4. Kar S, Deb M, Sengupta D, Shilpi A, Parbin S, Torrisani J, Pradhan S, Patra SK: An insight into the various regulatory mechanisms modulating Human DNA Methyltransferase 1 stability and function. Epigenetics 2012, 7: 994-1007.
5. Jones PA, Liang G: Rethinking how DNA methylation patterns are maintained. Nat Rev Gen 2009, 10: 805-811.
6. Denis H, Ndlovu MN, Fuks F: Regulation of mammalian methyltransferase: a route to new mechanisms. EMBO Rep 2011, 12: 647-656.
7. Weber M, Schubeler D: Genomic patterns of DNA methylation: targets and function of an epigenetic mark. Curr Opin Cell Biol 2007, 19: 273-280.
8. Jeltsch A: Reading and writing DNA methylation. Nat Struct Mol Biol 2008, 15: 1003-1004.
9. Wade PA: Methyl CpG binding proteins: coupling chromatin architecture to gene regulation. Oncogene 2001, 20: 3166-3173.
10. Deb M, Kar S, Sengupta D, Shilpi A, Parbin S, Rath SK, Londhe V, Patra SK: Chromatin dynamics: H3K4 methylation and H3 variant replacement during development and in cancer. Cell Mol Life Sci 2014, 71: 3439-3463.
11. Ballestar E, Esteller M: The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis 2002, 23: 1103-1109.
12. Fatemi M, Wade PA: MBD family proteins: reading the epigenetic code. J Cell Sci 2006, 119: 3033-3037.
13. Dhasarathy A, Wade PA: The MBD protein family-reading an epigenetic mark? Mutat Res 2008, 647: 39-43.
14. Bogdanovic O, Veenstra GJ: DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma 2009, 118: 549-565.
15. Sasai N, Defossez PA: Many paths to one goal? The proteins that recognize methylated DNA in eukaryotes. Int J Dev Biol 2009, 53: 323-334.
16. Wade PA: Methyl CpG-binding protiens and transcriptional repression. Bioessays 2001, 23: 1131-1137.
17. Patra SK, Patra A, Zhao H, Carroll P, Dahiya R: Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2. Biochem Biophys Res Commun 2003, 302: 759-766.
18. Clouaire T, Stancheva I: Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin? Cell Mol Life Sci 2008, 65: 1509-1522.
19. Vaissiere T, Sawan C, Herceg Z: Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res 2008, 659: 40-48.
20. Baylin SB: DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2005, 2: S4-S11.
21. Esteller M: Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 2007, 16: 50-59.
22. Strathdee G, Brown R: Aberrant DNA methylation in cancer: potential clinical interventions. Expert Rev Mol Med 2002, 4: 1-17.
23. Das PM, Singal R: DNA methylation and cancer. J Clin Oncol 2004, 22: 4632-4642.
24. Luczak MW, Jagodzinski PP: The role of DNA methylation in cancer development. Folia Histochem Cytobiol 2006, 44: 143-154.
25. McCabe MT, Brandes JC, Vertino PM: Cancer DNA methylation: molecular mechanisms and clinical implications. Clin Cancer Res 2009, 15: 3927-3937.
26. Lopez-Serra L, Esteller M: Proteins that bind methylated DNA and human cancer: reading the wrong words. Br J Cancer 2008, 98: 1881-1885.
27. Lopez-Serra L, Ballestar E, Fraga MF, Alaminos M, Setien F, Esteller M: A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer. Cancer Res 2006, 66: 8342-8346.
28. Parry L, Clarke AR: The roles of the methyl-CpG binding proteins in cancer. Genes Cancer 2011, 2: 618-630.
29. Sansom OJ, Maddison K, Clarke AR: Mechanisms of disease: methyl-binding domain proteins as potential therapeutic targets in cancer. Nat Clin Pract Oncol 2007, 4: 305-315.
30. Ballestar E, Paz MF, Valle L, Wei S, Fraga MF, Espada J, Cigudosa JC, Huang TH, Esteller M: Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J 2003, 22: 6335-6345.
31. Lopez-Serra L, Ballestar E, Ropero S, Setien F, Billard LM, Fraga MF, Lopez-Nieva P, Alaminos M, Guerrero D, Dante R, Esteller M: Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of Methyl-CpG binding domain proteins. Oncogene 2008, 27: 3556-3566.
32. Egger G, Liang G, Aparicio A, Jones PA: Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004, 429: 457-463.
33. Rodenhiser D, Mann M: Epigenetics and human disease: translating basic biology into clinical applications. Can Med Assoc J 2006, 174: 341-348.
34. Tone S, Sugimoto K, Tanda K, Suda T, Uehira K, Kanouchi H, Samejima K, Minatogawa Y, Earnshaw WC: Three distinct stages of apoptotic nuclear condensation revealed by time-lapse imaging, biochemical and electron microscopy analysis of cell-free apoptosis. Exp Cell Res 2007, 313: 3635-3644.
35. Hsu A, Wong CP, Yu Z, Williams DE, Dashwood RH, Ho E: Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells. Clin Epigenetics 2011, 3: 3.
36. Jones PA, Baylin SB: The epigenomics of cancer. Cell 2007, 128: 683-692.
37. Vilain A, Vogt N, Dutrillaux B, Malfoy B: DNA methylation and chromosome instability in breast cancer cell lines. FEBS Lett 1999, 460: 231-234.
38. Mirza S, Sharma G, Parshad R, Gupta SD, Pandya P, Ralhan R: Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of naturalcompounds on DNA methyltransferases and associated proteins. J Breast Cancer 2013, 16: 23-31.
39. Schmittgen TD, Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3: 1101-1108.
40. Patra A, Deb M, Dahiya R, Patra SK: 5-Aza-2'-deoxycytidine stress response and apoptosis in prostate cancer. Clin Epigenetics 2011, 2: 339-348.
41. Patra SK, Patra A, Dahiya R: Histone deacetylase and DNA methyltransferase in human prostate cancer. Biochem Biophys Res Commun 2001, 287: 705-713.
42. Patra SK, Patra A, Zhao H, Dahiya R: DNA methyltransferase and demethylase in human prostate cancer. Mol Carcinog 2002, 33: 163-171.
43. Patra SK, Bettuzzi S: Epigenetic DNA-(Cytosine-5-Carbon) Modifications: 5-Aza-2'-Deoxycytidine and DNA-Demethylation. Biochem Mosc 2009, 74: 613-619.